Screening Identification 스크리닝 식별

Discover more insights into Screening Identification 스크리닝 식별

Keywords frequently search together with Screening Identification 스크리닝 식별

Narrow sentence examples with built-in keyword filters

More Screening Identification 스크리닝 식별 sentence examples

10.1007/7355_2019_86

Fluorescent molecular imaging (FMI) has tremendous potential for improving the efficiency of drug screening, evaluating drug effects, accelerating the process, and markedly reducing the cost of new drug development from initial target validation and high-throughput screening identification campaigns to the final human translation phases.

FMI(Fluorescent Molecular Imaging)는 약물 스크리닝의 효율성을 개선하고, 약물 효과를 평가하고, 프로세스를 가속화하고, 초기 표적 검증 및 고처리량 스크리닝 식별 캠페인에서 최종 인간 번역에 이르기까지 신약 개발 비용을 현저히 절감할 수 있는 엄청난 잠재력을 가지고 있습니다. 단계.

More Screening Identification 스크리닝 식별 sentence examples

10.1007/s00735-019-1010-1

Die häufigsten Risikofaktoren, die durch das Screening Identification of Seniors at Risk (ISAR) vordefiniert wurden, waren Multimedikation, vorangegangene Hospitalisationen, ein vorbestehender Hilfebedarf und eine akute Veränderung des Hilfebedarfs.

위험에 처한 고령자 선별 검사(ISAR)에 의해 사전 정의된 가장 일반적인 위험 요소는 복합 약물, 이전 입원, 기존의 지원 필요성 및 지원 필요성의 급격한 변화였습니다.

Learn more from Screening Identification 스크리닝 식별

Keywords related to Screening

Screening Guide Screening History Screening 2002 Screening Mammogram Screening Ionic Screening Strategy Screening Practices Screening For Screening Decisions Screening Pilot Screening Approach Screening Outreach Screening Beliefs Screening Center Screening Panel Screening Experiences Screening Mri Screening Length Screening Method Screening Behaviors Screening Practice Screening System Screening Cannabinoids Screening Protocol Screening Development Screening Model Screening Device Screening Followed Screening Inventory Screening Und Screening Mechanisms Screening Asymptomatic Screening Applications Screening Drugs Screening Campaigns Screening Improves Screening Urine Screening Round Screening Effectiveness Screening Fitokimia Screening Barriers Screening Characterization Screening Performance Screening Programmes Screening Modality Screening Antimicrobial Screening Selection Screening Experiments Screening Technique Screening Von Explore More

Keywords related to Identification

Facilitate Identification Wireless Identification Phenotype Identification Materials Identification Ligand Identification Mimo Identification Service Identification Remote Identification Isomer Identification Mci Identification Gland Identification Stiffness Identification Material Identification Parametric Identification Pattern Identification Task Identification Numerical Identification Organizational Identification Timely Identification Camera Identification Correct Identification Vessel Identification Rna Identification Fracture Identification Biomarkers Identification Children Identification Part Identification Qtl Identification Structures Identification Blind Identification Function Identification Nonparametric Identification Voice Identification Employee Customer Identification Boundary Identification Frame Identification Conditions Identification Nerve Identification Radiological Identification Proteome Wide Identification Genome Wide Identification Selective Identification Radiofrequency Identification Region Identification Classification Identification Simultaneous Identification Response Identification Strain Identification Patients Identification Mechanism Identification Explore More

Screening Identification 스크리닝 식별

Screening Identification 스크리닝 식별

Encyclopedia 백과사전

Sep 30, 2023

Screening Identification(스크리닝 식별)란 무엇입니까?

Screening Identification 스크리닝 식별 - Fluorescent molecular imaging (FMI) has tremendous potential for improving the efficiency of drug screening, evaluating drug effects, accelerating the process, and markedly reducing the cost of new drug development from initial target validation and high-throughput screening identification campaigns to the final human translation phases. ^[1] Die häufigsten Risikofaktoren, die durch das Screening Identification of Seniors at Risk (ISAR) vordefiniert wurden, waren Multimedikation, vorangegangene Hospitalisationen, ein vorbestehender Hilfebedarf und eine akute Veränderung des Hilfebedarfs. ^[2]
FMI(Fluorescent Molecular Imaging)는 약물 스크리닝의 효율성을 개선하고, 약물 효과를 평가하고, 프로세스를 가속화하고, 초기 표적 검증 및 고처리량 스크리닝 식별 캠페인에서 최종 인간 번역에 이르기까지 신약 개발 비용을 현저히 절감할 수 있는 엄청난 잠재력을 가지고 있습니다. 단계. ^[1] 위험에 처한 고령자 선별 검사(ISAR)에 의해 사전 정의된 가장 일반적인 위험 요소는 복합 약물, 이전 입원, 기존의 지원 필요성 및 지원 필요성의 급격한 변화였습니다. ^[2]